Natriumoxybat Kalceks (Sodium Oxybate)

Sodium Oxybate, the active ingredient in Natriumoxybat Kalceks, is a gamma‑hydroxybutyrate (GHB) central nervous system depressant presented as an oral solution for oral administration. It is indicated for the management of narcolepsy with cataplexy and for reducing excessive daytime sleepiness in adult patients.

GNH USA supplies Natriumoxybat Kalceks as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with distribution channels aligned to EU regulatory standards. The product complies with European pharmacopeial specifications and is manufactured under strict quality‑assured processes.

Sodium Oxybate acts on the central nervous system to improve sleep architecture in narcolepsy.

- Narcolepsy with cataplexy: reduces frequency and severity of cataplexy episodes. - Excessive daytime sleepiness in narcolepsy: improves wakefulness and reduces sleep attacks. - Disrupted nocturnal sleep in narcolepsy: enhances slow‑wave sleep and consolidates nighttime rest.

Sodium Oxybate may be associated with a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Dizziness: transient light‑headedness. - Headache: pressure or throbbing sensation. - Fatigue: increased tiredness after dosing.

Serious or Rare Side Effects: - Respiratory depression: reduced breathing effort, potentially life‑threatening. - Seizures: rare occurrence of convulsive episodes. - Severe hypotension: marked drop in blood pressure. - Abuse potential: risk of dependence and misuse.

When prescribing Sodium Oxybate, clinicians should observe several safety considerations.

- Contraindication: avoid use in patients with known hypersensitivity to sodium oxybate or GHB. - Monitoring: assess respiratory function and blood pressure regularly during therapy. - Pregnancy: limited data; use only if potential benefit justifies potential risk to fetus. - Breastfeeding: sodium oxybate is excreted in breast milk; advise against nursing while on treatment. - Driving: patients should be cautioned about impaired alertness and avoid operating machinery until they know how the drug affects them. - Store at ambient temperature: keep below 25°C in the original container, protect from moisture and light.

Sodium Oxybate can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Central nervous system depressants: concurrent use with alcohol, benzodiazepines or opioids may cause profound respiratory depression. - Sodium‑containing medications: may increase total sodium load, requiring monitoring in patients with cardiovascular disease.

Moderate Interactions (Monitor Closely): - Antidepressants (especially SSRIs): may enhance serotonergic effects, requiring observation for serotonin syndrome. - Antihypertensives: sodium oxybate can lower blood pressure, potentially necessitating dose adjustment. - Anticonvulsants: may alter seizure threshold, requiring clinical vigilance.